Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A (2025)
Therapeutic evaluation of [²¹²Pb]Pb-AB001 and [¹⁷⁷Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer
Eur J Nucl Med Mol Imaging (in press)
DOI 10.1007/s00259-025-07330-y, PubMed 40397137

Lindland K, Westrøm S, Dragovic SM, Li RG, Malenge MM, Ho B, Juzeniene A, Bønsdorff TB (2025)
Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy
Mol Cancer Ther (in press)
DOI 10.1158/1535-7163.MCT-24-1060, PubMed 40495114

Liukaityte R, Stenberg VY, Kleinauskas A, Juzenas P, Urbanucci A, Juzeniene A (2025)
Combination of PSMA targeting alpha-emitting radioligand [²¹²Pb]Pb-AB001 with BET bromodomain inhibitors in in vitro prostate cancer models
Med Oncol, 42 (8), 362
DOI 10.1007/s12032-025-02925-9, PubMed 40694184